[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354452-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-354452-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","childhood-cancer-survival-in-africa-asia-latin-america-and-the-caribbean-during-2008-2017-survcan-3","Childhood cancer survival in Africa, Asia, Latin America and the Caribbean, during 2008-2017 (SURVCAN-3)","","Accurate estimates of childhood cancer survival are vital for strengthening health systems, yet population-based evidence in low-resource settings remains limited. This study benchmarks survival using data from 47 population-based cancer registries across Africa, Latin America and the Caribbean, and Asia. It estimates 1-, 3-, and 5-year observed survival by diagnostic group, country, region, Human Development Index, income, and sex, leveraging follow-up in Rwanda.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/childhood-cancer-survival-in-africa-asia-latin-america-and-the-caribbean-during-2008-2017-survcan-3/354452/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/childhood-cancer-survival-in-africa-asia-latin-america-and-the-caribbean-during-2008-2017-survcan-3/354452.png","ImageObject",300,407,{"name":42,"@type":43},"Fans","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the goal of the SURVCAN-3 study?","Question",{"text":63,"@type":64},"To provide reliable and comparable population-based childhood cancer survival estimates for Africa, Asia, Latin America, and the Caribbean.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which data sources and follow-up periods were used?",{"text":68,"@type":64},"The study included 16 821 children from 47 population-based cancer registries, using Cancer Survival in Countries in Transition data (2008–2012 diagnoses, followed to 2014) and Rwanda data (2013–2017, followed to 2022).",{"name":70,"@type":61,"acceptedAnswer":71},"How were survival outcomes estimated and by what factors?",{"text":72,"@type":64},"Observed 1-, 3-, and 5-year survival were estimated using the Kaplan–Meier method, stratified by diagnostic group, country, region, Human Development Index, income, and sex.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354452,1790414898,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},5909892330395,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","JNCI: Journal of the National Cancer Institute, 2026, 118(7), 1183–1194  \n[https://doi.org/10.1093/jnci/djaf321](https://doi.org/10.1093/jnci/djaf321)  \nAdvance Access Publication Date: December 15, 2025  \nArticle  \nChildhood cancer survival in Africa, Asia, Latin America and the Caribbean, during 2008-2017 (SURVCAN-3): a population-based benchmarking study of 16 821 children  \nDagrun Slettebø Daltveit , PhD1,2, 􀀃 , Eileen Morgan , PhD1, Aude Bardot , MSc1, Eva Steliarova-Foucher , PhD1, Amanuel Damie , MD3, Marc Hagenimana, MPH4, Nisrine Khoubila , PhD5, Florencia Moreno , MD6,  \nIsabelle Soerjomataram , PhD1  \n1Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France  \n2Section for Epidemiology and Medical Statistics, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway 3Department of Pathology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia  \n4Rwanda Biomedical Centre, Kigali, Rwanda  \n5Department of Hematology and Pediatric Oncology, Faculty of Medicine and Pharmacy, Hospital 20 August 1953, CHU Ibn Rochd, Hassan II University, Casablanca, Morocco  \n6Instituto Nacional del Cancer, Buenos Aires, Argentina  \n􀀃 Corresponding author: Dagrun Slettebø Daltveit, PhD, Department of Global Public Health and Primary Care, University of Bergen, P.B. 7804, N-5020 Bergen, Norway ([dagrun.daltveit@uib.no](dagrun.daltveit@uib.no)) .  \nAbstract  \nBackground: Accurate information on childhood cancer survival is essential for improving health systems. Survival is believed to below in low-resource countries, but population-based survival estimates are scant. We aim to provide reliable and comparable survival estimates in these settings.  \nMethods: We included 16 821 patients from 47 population-based cancer registries in 23 countries in Africa, Latin America and the Caribbean, and Asia. We used the Cancer Survival in Countries in Transition project data (children aged younger than 15 years, diagnosed 2008-2012, followed until 2014) and data from Rwanda (2013-2017, followed until 2022) . We estimated 1-year, 3-year, and 5-year observed survival using the Kaplan–Meier method, by diagnostic group, country, region, Human Development Index, income, and sex.  \nResults: Survival was higher in registries included from the Caribbean (namely, Puerto Rico [United States], Martinique [France]) and Central America (Costa Rica), Asia, and the Middle East and North Africa compared with those included from South America and sub-Saharan Africa. Survival correlated with the Human Development Index. For leukemia, 3-year survival varied from 30.4%(95% confidence interval [CI] ¼ 12.4% to 50.6%) in Kenya to 89.5%(95% CI ¼ 83.8% to 93.2%) in Puerto Rico; for central nervous system tumors from 32.0%(95% CI ¼ 13.9% to 51.8%) in Algeria to 79.3%(95% CI ¼ 69.1% to 86.5%) in Puerto Rico. The findings should be interpreted with care, as registry coverage varies and may not reflect national and regional survival.  \nConclusion: The variability of the population-based survival estimates across predominantly low- and middle-income countries highlights gaps in cancer registration, access to care, and quality of care. This study provides benchmark data for the World Health Organization Global Initiative for Childhood Cancer generated by population-based cancer registries, which should be supported in all countries.  \nIntroduction  \nIn 2022, more than 200 000 children (aged 0-14 years) were diagnosed with cancer, and approximately 75000 children aged younger than 15 years died of cancer worldwide, according to the estimates of the Global Cancer Observatory.1 Childhood cancer incidence is highest in North America and Europe, yet the vast majority (94%) of cancer deaths occur in Africa, South America and the Caribbean, and Asia, with estimated mortality almost twice the rate in Europe and North America.1 The current 5-year childhood cancer survival in high-income countries is above 80% .2","cbCaigAFUi2wOZ61","https://ap.wps.com/l/cbCaigAFUi2wOZ61","pdf",2192843,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the goal of the SURVCAN-3 study?\",\"answer\":\"To provide reliable and comparable population-based childhood cancer survival estimates for Africa, Asia, Latin America, and the Caribbean.\"},{\"question\":\"Which data sources and follow-up periods were used?\",\"answer\":\"The study included 16 821 children from 47 population-based cancer registries, using Cancer Survival in Countries in Transition data (2008–2012 diagnoses, followed to 2014) and Rwanda data (2013–2017, followed to 2022).\"},{\"question\":\"How were survival outcomes estimated and by what factors?\",\"answer\":\"Observed 1-, 3-, and 5-year survival were estimated using the Kaplan–Meier method, stratified by diagnostic group, country, region, Human Development Index, income, and sex.\"}]","Childhood cancer survival in Africa, Asia, Latin America and the Caribbean, during 2008-2017 (SURVCAN-3) | PDF",1790110695,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a01e29dd19d35ecc2401654f0a47308.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/42475d23beda5626d10491c772c9f6df.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d74a932347cf09993c162fadee92038.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be6e7b9aaffb16237cb2a8108b78cda7.webp",980,1287]